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Abstract
Background: Free radicals generated in biological systems by cigarette smoke (CS) inhalation can
cause oxidative stress in tissues, resulting in lipid peroxidation (LPO). In view of the antioxidant
properties of α -tocopherol (AT), in the present study, effects of AT on antioxidant defence system
and LPO were investigated in mice inhaling CS for different time intervals.
Results: Male Balb/c mice were fed orally with AT (5 I.U./Kg.b.wt.) and /or exposed to CS for 2,
4, 6 or 8 weeks. No effect was observed on body growth, diet consumption, water intake and lung
weight due to AT and /or CS treatment in any of the groups as compared to their control
counterparts. After two weeks of treatment, no change in LPO, reduced glutathione (GSH) levels
and antioxidant enzymes were observed except for glutathione reductase (GR) which increased in
all the treated groups. A significant increase in pulmonary LPO levels was observed in mice exposed
to CS inhalation for 4, 6 or 8 weeks. There was a gradual increase in the LPO levels as the extent
of CS inhalation increased from 4 to 8 weeks. However, the extent of increase in LPO levels due
to CS exposure for 4, 6 or 8 weeks in the mice treated with AT was comparatively less. A significant
decrease in the GSH levels was also observed in all the animals exposed to CS for 4, 6 or 8 weeks.
There was a significant increase in the activities of catalase, glutathione peroxidase (GSH-Px) and
GR observed in all the groups exposed to CS for 4,6 or 8 weeks. The increase in above antioxidant
enzymes seems to be insufficient to combat the oxidative stress posed by CS inhalation. There was
a marked decrease observed in the LPO levels in the animals treated with AT alone for 4, 6, or 8
weeks, when compared to their control counterparts. However, the supplementation of AT for 4,
6 or 8 weeks demonstrated a significant increase in GSH levels.
Conclusion: It appears from our studies that AT exhibits its antioxidant role either directly by
scavenging the oxidative species or indirectly by modulating the GSH levels.
Background
Cigarette smoke is a heterogeneous aerosol, which con-
tains more than 4000 chemicals [1]. These include vari-
ous compounds, which are capable of causing an
increase in the generation of various reactive oxygen spe-
cies like O2
•-, H2O2, OH•, ROO•. These reactive oxygen
species in turn are capable of initiating and promoting
oxidative damage in the form of lipid peroxidation [2,3].
Cigarette smoking may thus be associated with an in-
crease in the incidence and severity of various diseases
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like cancer, chronic obstructive lung disease and athero-
sclerosis [4].
Various organs may control or prevent the damaging ef-
fects of the oxidant species by enzymatic and non-enzy-
matic antioxidant defence systems. These include
enzymes like superoxide dismutase (SOD), catalase and
GSH-Px. Certain vitamins like α -tocopherol [5] and
ascorbic acid [6] are also suggested to have a strong free
radical scavenging properties. The deleterious effects of
the free radicals are kept under check by a delicate bal-
ance between the rate of their production and elimina-
tion by the different antioxidant systems. Any shift in
this critical balance could result in an increase in the per-
oxidative stress and may lead to cellular damage.
Although there is not enough evidence that indicates in-
creased intake of antioxidant nutrients is beneficial, the
observation that smokers have lower circulating levels of
certain nutrients raises concern [4]. There is evidence,
which suggests that supplementation with antioxidants
like AT, might protect smokers from oxidative damage
and could reduce risk from cancer or other diseases
caused by free radicals associated with smoking [7].
However, there are reports suggesting that the supple-
mentation of vitamins like AT might not have a beneficial
role in combating oxidative stress [8]. Therefore, the
present study was designed to investigate the antioxi-
dant role of AT in lungs of mice exposed to CS insult for
varying duration.
Results
There was no significant effect observed on body growth,
organ weight, daily dietary consumption and water in-
take with CS inhalation and/or AT supplementation for
2, 4, 6 or 8 weeks in balb/c mice. Two weeks of CS inha-
lation and/or AT treatment did not show any significant
difference in LPO, GSH levels and activities of catalase,
GSH-Px or SOD when inter group comparisons were
made. However, CS inhalation showed a significant in-
crease in the GR activity in both AT + smoked and only
smoked group. Moreover, a significant increase in GR ac-
tivity was also observed with AT supplementation (from
7.40 ± 0.40 to 8.51 ± 0.33 nmole NADPH consumed min-
1 mg protein-1) (Table 1).
Table 1: Effect of cigarette smoke and/ or AT on pulmonary antioxidant defence system in male balb/c mice over 2 weeks of treatment
Parameters Sham Smoked AT Smoked + AT
LPO 16.05 ± 0.56 16.24 ± 0.49 15.72 ± 0.52 15.91 ± 0.68
GSH 3.04 ± 0.06 2.92 ± 0.06 3.03 ± 0.08 2.96 ± 0.03
Catalase 30.40 ± 0.99 33.19 ± 1.24 32.61 ± 1.12 35.24 ± 2.35
GSH-Px 10.02 ± 0.27 10.01 ± 0.32 9.42 ± 0.29 9.52 ± 0.29
GR 7.40 ± 0.40 8.56 ± 0.28a
1 8.51 ± 0.33c
1 9.26 ± 0.22b
1
d
1
SOD 2.90 ± 0.12 2.92 ± 0.66 2.60 ± 0.38 2.79 ± 0.53
Values are in mean ± SD, n = 6–8 * Units are expressed as follows : Catalase (I.U. mg protein-1); GSH-Px and GR (nmol NADPH consumed min-1 
mg protein -1); GSH (µmol g tissue-1); SOD (I.U. mg protein-1); LPO (nmol malondialdehyde mg protein-1 30 min-1). Statistical analysisaSham vs. 
Smoked, bAT vs. AT + Smoked, cSham vs. AT, dSmoked vs. AT + Smoked a1, b1, c1, d1 : p < 0.05; a2, b2, c2, d2 : p < 0.01; a3, b3, c3, d3 : p < 0.001.
Table 2: Effect of cigarette smoke and/ or AT on pulmonary antioxidant defence system in male balb/c mice over 4 weeks of treatment
Parameters Sham Smoked AT Smoked + AT
LPO 16.53 ± 0.81 23.99 ± 0.45a
3 13.96 ± 0.70c
1 18.47 ± 0.56b
2
d
3
GSH 3.11 ± 0.02 2.80 ± 0.02a
3 3.27 ± 0.03c
1 2.68 ± 0.04b
3
d
2
Catalase 29.78 ± 1.65 39.01 ± 1.64a
1 34.51 ± 1.29c
1 39.18 ± 3.02b
1
GSH-Px 10.50 ± 0.27 15.05 ± 1.04a
2 7.46 ± 0.52c
2 11.13 ± 0.28b
3
d
2
GR 7.06 ± 0.11 10.96 ± 0.18a
3 9.82 ± 0.19c
3 12.36 ± 0.18b
3
d
2
SOD 2.84 ± 0.24 2.86 ± 0.24 2.95 ± 0.13 2.97 ± 0.14
Values are in mean ± SD, n = 6–8 *Same as in Table 1BMC Biochemistry 2001, 2:14  http://www.biomedcentral.com/1471-2091/2/14
Table 2 depicts the effects of CS inhalation and /or AT
supplementation on pulmonary antioxidant enzymes af-
ter 4 weeks of treatment. In this phase of study it was ob-
served that CS inhalation triggered LPO both in smoked
and AT + smoked group. However, the extent of increase
in LPO levels was comparatively less in the AT + smoked
group. LPO levels also showed a significant decline from
16.53 ± 0.81 to 13.96 ± 0.70 nmoles MDA mg protein-1 30
min-1 when mice were treated with AT (5 I.U./kg b.wt)
for 4 weeks. Observations regarding GSH were exactly
opposite to that of LPO in this phase of study. CS inhala-
tion decreased the levels of GSH in both the smoked and
AT + smoked group, whereas an increase in the levels of
GSH was observed in AT supplemented animals as com-
pared to their control counterparts. CS inhalation in-
duced catalase, GSH-Px and GR activities without
affecting the SOD activity in the smoked group as well as
AT + smoked group. AT supplementation enhanced GR
and catalase activities as compared to their controls,
whereas a decline in GSH-Px from 10.50 ± 0.27 to 7.46 ±
0.52 nmole NADPH consumed min-1mg protein-1 was
observed in this group.
Table 3 depicts extension of CS inhalation and /or AT ad-
ministration from 4 to 6 weeks. It showed similar effects
on LPO and GSH levels and other antioxidant enzymes
studied as were seen after 4 weeks of treatment. 8 weeks
of supplementation of AT and CS inhalation showed sim-
ilar trends as seen after 4 and 6 weeks of treatment (Ta-
ble 4). However, no increase in catalase activity was seen
in the group treated with AT for 8 weeks. Moreover, CS
inhalation also could not induce GR activity in the AT +
smoked group as compared to AT group.
Discussion
Cigarette smoke has been implicated as a major risk fac-
tor in many diseases such as pulmonary, cardiovascular
pathologies. The adverse action of the CS is due to the
presence of a large variety of compounds like nicotine,
benzo (a) pyrene, oxidants, and free radicals that could
initiate, promote and/or amplify oxidative damage. Al-
though, CS is a major determinant of diseases related to
oxidative stress, the inter individual variations in inci-
dence and extent of these diseases are many [9]. Reasons
like genetic susceptibility, extent of exposure to CS and/
or presence of certain antioxidant micronutrients like AT
in the diet of the individuals could be attributed to these
variations.
Table 3: Effect of cigarette smoke and/ or AT on pulmonary antioxidant defence system in male balb/c mice over 6 weeks of treatment
Parameters Sham Smoked AT Smoked + AT
LPO 16.03 ± 0.38 25.60 ± 0.49a
3 14.37 ± 0.33c
2 19.01 ± 0.46b
3
d
2
GSH 3.06 ± 0.03 2.54 ± 0.03a
3 3.97 ± 0.04 2.65 ± 0.02'b
2
Catalase 28.6 ± 0.95 38.65 ± 1.76a
2 36.02 ± 2.58c
1 41.33 ± 2.04b
1
GSH-Px 9.17 ± 0.13 16.73 ± 0.60a
3 6.52 ± 0.42c
2 11.34 ± 0.87b
2
d
2
GR 7.58 ± 0.26 12.75 ± 0.49a
3 11.21 ± 0.10c
3 12.19 ± 0.09b
3
SOD 2.71 ± 0.06 2.78 ± 0.13 2.77 ± 0.38 2.97 ± 0.46
Values are in mean ± SD, n = 6–8 *Same as in Table 1
Table 4: Effect of cigarette smoke and/ or AT on pulmonary antioxidant defence system in male balb/c mice over 8 weeks of treatment
Parameters Sham Smoked AT Smoked + AT
LPO 16.07 ± 0.41 29.92 ± 0.45a
3 14.03 ± 0.35c
2 20.89 ± 0.56b
3
d
3
GSH 2.94 ± 0.05 2.23 ± 0.02a
3 3.76 ± 0.02c
1 2.37 ± 0.03b
3
d
2
Catalase 27.38 ± 0.97 37.71 ± 1.92a
2 28.29 ± 1.06 43.13 ± 6.22b
1
GSH-Px 9.79 ± 0.23 21.94 ± 0.33a
3 6.62 ± 0.44c
1 17.77 ± 0.74b
3
d
2
GR 6.88 ± 0.35 11.34 ± 0.63a
3 9.63 ± 0.09c
2 9.97 ± 0.16d
1
SOD 2.45+0.08 2.62+0.23 2.61+0.60 3.01+0.16
Values are in mean ± SD, n = 6–8 *Same as in Table 1BMC Biochemistry 2001, 2:14  http://www.biomedcentral.com/1471-2091/2/14
In the first phase of investigation, where mice were sub-
jected to CS inhalation and/or were fed with AT (5 I.U./
kg.b.wt.) for 2 weeks, no significant change in pulmonary
LPO, GSH content or any of the enzymatic antioxidants
was observed, except for GR. An increase in GR activity
was observed in all the groups studied. It seems that the
treatment of CS inhalation for 2 weeks was not enough to
pose any significant oxidative stress and thereby no in-
crease in LPO. It may be possible that 2 weeks of CS was
not enough to tilt the balance between the oxidative
stress due to CS and the endogenous antioxidants. At the
same time, AT supplementation for two weeks also
seems to be unable to effect the levels of GSH. The chang-
es in GR after 2 weeks of CS and AT seem to be a nonspe-
cific response.
As the exposure of CS to the mice was extended from 2 to
4, 6 and 8 weeks, a significant increase in the LPO levels
was observed. However, the extent of the increase in the
pulmonary LPO levels in the AT + smoked group was
comparatively low as compared to the animals not fed
with AT and only exposed to CS. It was also observed that
as the exposure to CS was extended from 4 to 6 and then
to 8 weeks, there was a corresponding increase in the
pulmonary LPO levels in both, the smoked as well as the
AT + smoked group. However, the rate of increase of
LPO in case of AT + smoked animals were comparatively
less. These findings are suggestive of the fact that the in-
crease in the duration of exposure to cigarette smoke, en-
hances the oxidative stress and thereby the LPO levels.
However, AT appears to be responsible for the retarded
increase of LPO in the AT + smoked group with increase
in the duration of smoking.
In the sham exposed mice fed with AT for 4, 6 and 8
weeks, there was a significant decrease in the LPO levels
observed as compared to their control counter parts.
These observations too point towards the antioxidant
properties of AT. Royack et al [10] have also reported
that vitamin E as such may have the potential to reduce
oxidative damage caused by hydroxyl free radicals.
In our studies, a significant decrease in the GSH levels
was observed in both the smoked as well as AT + smoked
groups and concomitantly there was an increase in the
LPO levels. Therefore, the depletion of GSH seems to be
associated with the increase of LPO. Younes and Siegers
[11] have also observed that depletion of GSH enhances
LPO. We have also observed that there was an increase in
GSH levels in the AT fed group as compared to its control
counterparts after 4, 6 and 8 weeks of treatment. On the
other hand, in this group, LPO levels decreased indicat-
ing the antioxidant role of GSH in combating the oxida-
tive stress. These findings correlate with our earlier
report [12]. The unchanged levels of LPO in the presence
of unaltered GSH contents in the animals treated for 2
weeks with AT supports our view that levels of GSH play
an important role in combating the oxidative stress.
We also observed that the other antioxidant enzymes like
catalase, GSH-Px, and GR increased significantly in both
the smoked as well as AT + smoked groups after 4, 6 and
8 weeks of CS exposure but still could not prevent the in-
crease in LPO levels. It seems that this increase in the en-
zyme levels perhaps was a nonspecific response to the
treatment or could be that this increase was not signifi-
cant to combat the oxidative stress posed by CS expo-
sure.
Conclusions
It seems from our studies that AT plays an important role
in combating the oxidative stress directly and/or
through its affects on GSH levels. Moreover, studies re-
lated to the exact dose of AT, in order to quench oxidative
stress in much more affective manner need to be worked
on. Work in this direction is in progress in our laborato-
ry.
Materials and Methods
Male Balb/c mice weighing 20–25 gms, procured from
the university animal house were used in the present
study. Animals were fed on standard commercial pellet
diet (Hindustan Lever Ltd) and had free access to water.
After an acclimatization of one week, in our animal
room, the animals were randomly divided into four
groups and followed the treatment as shown in the Table
5.
AT or mustard oil (vehicle) were administered orally,
everyday using a blunt tip canula. Mice in of the smoked
groups were subjected to cigarette smoke inhalation as
described earlier (13,14). In short 5–6 animals were ex-
posed at a time to smoke from five commercially availa-
ble filter tipped cigarettes. The procedure continued for
60 minutes every day in an inhalation chamber (8.21 lit-
Table 5: 
S.No. Group Treatment
1. Sham 0.1 ml of mustard oil/kg b.wt.
2. Smoked 0.l ml of mustard oil/kg b.wt + cigarette 
smoke inhalation.
3. AT 5 I.U.α -tocopherol/ kg b.wt in 0.1 ml of 
mustard oil.
4. AT+ 
smoked
5 I.U.α -tocopherol/kg b.wt in 0.1 ml of mus-
tard oil + cigarette smoke inhalation.
(Doses Standardized in our laboratory)BMC Biochemistry 2001, 2:14  http://www.biomedcentral.com/1471-2091/2/14
ers). The chamber consisted of separate inlets for smoke
and fresh air. After exposure of smoke from each ciga-
rette, mice were exposed to only fresh air for a five
minute interval and then another cigarette was lit. A
valve attached at the outlet to a suction pump controlled
the airflow (141 cc/min) through the chamber. Each cig-
arette took approximately 8 minutes to burn completely.
No visible stress was observed on the animals while be-
ing exposed to the smoke. For comparison control ani-
mals (Sham exposed) were exposed to only fresh airflow
in an identical chamber, where the cigarette was re-
placed by filter alone.
AT supplementation and cigarette smoke inhalation con-
tinued for either 2,4,6 or 8 weeks duration. After their re-
spective treatments, mice from each group were
sacrificed by exsanguination under light ether anesthesia
between 7–8 hours after an over night fasting. The tho-
racic cavities of the animals were opened and the lungs
excised and immediately perfused with cold 0.15 M KCl
containing, 50 mM Tris-HCl buffer, pH 7.4. Tissues were
homogenized and diluted to a concentration of 1 gm wet
weight/4 ml of 0.05 M phosphate buffer, pH 7.4. Tissue
homogenates were centrifuged at 10,000 ×  g for 20 min-
utes at 4°C. The supernatants thus obtained were used
for different estimations. GSH-Px was assayed by the
method described by Flohe and Gunzler (15). Catalase
activity was measured by the method of Luck [16]. SOD
activity was determined by the method of Kono [17]. GR
activity was assayed as reported by Carlberg and Man-
nervik [18]. GSH was estimated in the whole tissue ho-
mogenate by the method of Moron et al [19]. Lipid
peroxide levels were assayed as described by Trush et al
[20]. Protein was determined by the method of Lowry et
al [21]. The statistical significance of inter group differ-
ence of various parameters were determined by unpaired
students 't' test.
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